Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial
YAO Ling-Song, LIN Xin-Zhu, HUANG Jing, TANG Li-Xia
Department of Neonatology, Women and Children's Hospital, School of Medcine, Xiamen University/Xiamen Key Laboratory of Perinatal-Neonatal Infection, Xiamen, Fujian 361003, China
Abstract Objective To study the clinical effect of an additional maintenance dose (5 mg/kg) of caffeine citrate injection at 1 hour before ventilator weaning in improving the success rate of ventilator weaning in preterm infants (gestational age ≤32 weeks) with respiratory distress syndrome (RDS) on mechanical ventilation. Methods A total of 338 preterm infants with RDS (gestational age of ≤32 weeks) who were admitted to the Neonatal Intensive Care Unit of Xiamen Maternal and Child Health Hospital from January 2017 to December 2019 and treated with mechanical ventilation were enrolled. They were randomly divided into an observation group and a routine group, with 169 infants in each group. Both groups received early routine treatment with caffeine. The infants in the observation group received an additional maintenance dose of caffeine citrate injection at 1 hour before ventilator weaning. The two groups were compared in terms of reintubation rate and number of apnea episodes within 48 hours after ventilator weaning, changes in blood gas parameters, blood glucose, heart rate, and mean blood pressure at 2 hours after ventilator weaning, and incidence rates of major complications during hospitalization. Results Compared with the routine group, the observation group had significantly lower reintubation rate (P=0.034) and number of apnea episodes (≥2 times/day) (P=0.015) within 48 hours after ventilator weaning. Compared with the routine group at 2 hours after ventilator weaning, the observation group had a significantly higher pH value and a significantly lower arterial partial pressure of carbon dioxide (P < 0.05), while there were no significant differences between the two groups in arterial partial pressure of oxygen, blood glucose, heart rate, and mean blood pressure (P > 0.05). During hospitalization, the observation group had a significantly lower incidence rate of intraventricular hemorrhage than the routine group (P=0.048), but there were no significant differences between the two groups in the incidence rates of bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, and periventricular leukomalacia and mortality rate (P > 0.05). Conclusions An additional maintenance dose of caffeine citrate injection at 1 hour before ventilator weaning is safe and effective in improving the success rate of ventilator weaning in preterm infants with RDS and thus holds promise for clinical application.
YAO Ling-Song,LIN Xin-Zhu,HUANG Jing et al. Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial[J]. CJCP, 2021, 23(1): 31-36.
YAO Ling-Song,LIN Xin-Zhu,HUANG Jing et al. Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial[J]. CJCP, 2021, 23(1): 31-36.
Ferguson KN, Roberts CT, Manley BJ, et al. Interventions to improve rates of successful extubation in preterm infants:a systematic review and meta-analysis[J]. JAMA Pediatr, 2017, 171(2):165-174.
[2]
Alhersh E, Abushanab D, Al-Shaibi S, et al. Caffeine for the treatment of apnea in the neonatal intensive care unit:a systematic overview of meta-analyses[J]. Paediatr Drugs, 2020, 22(4):399-408.
[3]
邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版. 北京:人民卫生出版社, 2011.
[4]
Greenough A, Prendergast M. Difficult extubation in low birthweight infants[J]. Arch Dis Child Fetal Neonatal Ed, 2008, 93(3):F242-F245.
[5]
Cloherty JP, Eichenwald EC, Stark AR. Manual of Neonatal Care[M]. 6th Edition. Philadelphia:Lippincott Williams & Wilkins, 2007:332-342.
Goel S, Mondkar J, Panchal H, et al. Nasal mask versus nasal prongs for delivering nasal continuous positive airway pressure in preterm infants with respiratory distress:a randomized controlled trial[J]. Indian Pediatr, 2015, 52(12):1035-1040.
[8]
Schmölzer GM, Kumar M, Pichler G, et al. Non-invasive versus invasive respiratory support in preterm infants at birth:systematic review and meta-analysis[J]. BMJ, 2013, 347:f5980.
[9]
Walsh MC, Morris BH, Wrage LA, et al. Extremely low birthweight neonates with protracted ventilation:mortality and 18-month neurodevelopmental outcomes[J]. J Pediatr, 2005, 146(6):798-804.
[10]
Al-Mandari H, Shalish W, Dempsey E, et al. International survey on periextubation practices in extremely preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 2015, 100(5):F428-F431.
[11]
Shalish W, Kanbar L, Keszler M, et al. Patterns of reintubation in extremely preterm infants:a longitudinal cohort study[J]. Pediatr Res, 2018, 83(5):969-975.
[12]
Chawla S, Natarajan G, Shankaran S, et al. Markers of successful extubation in extremely preterm infants, and morbidity after failed extubation[J]. J Pediatr, 2017, 189:113-119.e2.
[13]
Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2019 update[J]. Neonatology, 2019, 115(4):432-450.
[14]
Moschino L, Zivanovic S, Hartley C, et al. Caffeine in preterm infants:where are we in 2020?[J]. ERJ Open Res, 2020, 6(1):00330-2019.
[15]
Natarajan G, Botica ML, Thomas R, et al. Therapeutic drug monitoring for caffeine in preterm neonates:an unnecessary exercise?[J]. Pediatrics, 2007, 119(5):936-940.
[16]
Abdel-Hady H, Nasef N, Shabaan AE, et al. Caffeine therapy in preterm infants[J]. World J Clin Pediatr, 2015, 4(4):81-93.
